geneoscopy
The Specialty Development Executive (SDE-CRC) promotes Geneoscopy's ColoSense® colorectal cancer screening test to healthcare providers across the West Territory, driving product adoption, education, and strategic business planning. The role involves extensive travel, relationship building with clinicians and key opinion leaders, and collaboration with internal teams to achieve sales goals.
Headquarters
St. Louis, Missouri, United States
Company Size
51-200 employees
Founded
2015
Geneoscopy is a biotechnology company focused on transforming gastrointestinal health through innovative, noninvasive stool-based molecular diagnostics. Powered by its proprietary stool-derived eukaryotic RNA (seRNA) technology platform, the company develops tests for colorectal cancer screening and inflammatory bowel disease monitoring, including ColoSense®, the first FDA-approved RNA-based stool test for colorectal cancer screening in adults 45 and older. Geneoscopy's mission is to empower patients and healthcare providers with precise, accessible diagnostic tools that help prevent, detect, and monitor gastrointestinal disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for geneoscopy.
Screening Sales Representative - Fort Wayne, IN
Exact Sciences Corporation
Screening Sales Representative
Abbott Laboratories
Screening Solutions Specialist
Abbott Laboratories
Screening Solutions Specialist
Abbott Laboratories
Associate Account Executive - Screening (Pine Bluff)
Guardant Health
Screening Sales Representative - Wayne, NJ
Exact Sciences Corporation